---
title: 'Associate Director, Clinical Scientist at Vir Biotechnology'
canonical: 'https://feeny.ai/job/associate-director-clinical-scientist-vir-biotechnology-san-francisco-kz6ttfjzvf2m'
type: 'job'
last_seen: '2026-10-17'
---

# Associate Director, Clinical Scientist at Vir Biotechnology

- **Company:** Vir Biotechnology
- **Location:** San Francisco, CA
- **Posted:** 2026-09-28
- **Last confirmed live:** 2026-10-17
- **Apply:** https://job-boards.greenhouse.io/virbiotechnologyinc/jobs/4738505005

## Job description

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.

Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

## THE OPPORTUNITY

Vir Bio is looking for an Associate Director, Clinical Scientist, to play a key role in the execution of oncology clinical studies, partnering closely with Clinical Operations, Medical Monitoring, Data Management, Biostatistics, and Regulatory teams to support study startup, conduct, analysis, and reporting.

This is a highly collaborative and hands-on role for an experienced clinical scientist who enjoys being close to the data, contributing to study design and execution, and helping advance programs from early development through key clinical milestones.

This role is based in our San Francisco headquarters with an expectation of being onsite at least three days per week.

## WHAT YOU'LL DO

- Serve as the Clinical Scientist for one or more oncology clinical studies, supporting study startup, execution, data review, and reporting activities
- Partner cross-functionally with Clinical Operations, Medical Monitoring, Data Management, Biostatistics, Regulatory, and other teams to support successful study conduct
- Contribute to protocol and informed consent development, including authoring, review, and resolution of cross-functional feedback
- Perform ongoing clinical data review, identify trends and potential issues, and collaborate with study teams to ensure high-quality data
- Support site-facing activities, including investigator meetings, study training, and responses to protocol-related questions
- Contribute to the preparation and review of clinical study reports, regulatory submissions, safety reports, and other clinical documents
- Participate in the review and interpretation of emerging clinical data and support study analyses and presentations

## WHO YOU ARE AND WHAT YOU BRING

- Advanced degree in Life Sciences, Nursing, Pharmacy, Medicine, or a related field (PhD, PharmD, MSN, NP, PA, or equivalent) preferred
- 7+ years of experience in oncology clinical research within biotechnology, pharmaceutical, CRO, or academic environments
- Experience supporting the design, conduct, and analysis of oncology clinical trials
- Strong understanding of GCP, ICH guidelines, and the clinical drug development process.
- Experience reviewing clinical trial data, identifying trends, and collaborating with cross-functional study teams
- Knowledge of protocol development, clinical trial operations, and study execution
- Strong communication, organizational, and problem-solving skills with the ability to manage multiple priorities in a fast-paced environment
- Collaborative, detail-oriented, and committed to delivering high-quality work

## #LI-AS1

#LI-Onsite

## WHO WE ARE AND WHAT WE OFFER

The expected salary range for this position is $176,500 to $246,500 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.

Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.

Applicants must currently be authorized to work for any employer in the U.S.  We are unable to sponsor or take over sponsorship of an employment Visa at this time.

All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.

This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs.  Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.

Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.

For hires based in the United States, Vir Biotechnology, participates in [E-Verify](https://www.e-verify.gov/sites/default/files/everify/posters/EVerifyParticipationPoster.pdf).

[Candidate Privacy Notice](https://www.vir.bio/candidate-notice/)

## About Vir Biotechnology

## Company Overview
- **One-liner**: Vir Biotechnology is a clinical-stage immunology company focused on engineering powerful antibody-based medicines to treat infectious diseases and cancer.
- **Entity Type**: Public (Ticker: VIR)
- **Headquarters**: San Francisco, California, United States
- **Founded**: 2016
- **Founders**: Not publicly available (the company was formed with founding investments from ARCH Venture Partners, the Bill & Melinda Gates Foundation, and others)

## Core Business
- **Primary Industry**: Biotechnology (Immunology, Infectious Disease, Oncology)
- **Target Customers**: Patients with serious infectious diseases (e.g., chronic hepatitis delta, COVID-19, Ebola) and specific cancers; the company's customers are effectively patients and healthcare systems, with revenue coming from partnerships and product sales.
- **Mission/Purpose**: "Power the immune system to transform lives" by delivering potentially transformative medicines for patients with high unmet medical needs.

## Products & Services
- **Next-Generation Antibody Platform**: A proprietary platform that enables the rapid discovery, optimization, and advancement of antibody candidates for infectious diseases.
- **PRO-XTEN® Protease-Releasable Masking Technology**: A platform (exclusive rights for oncology and infectious disease) used to engineer conditionally activated antibodies that are designed to be safer and more effective in treating cancer. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
- **Pipeline Programs**: The company’s pipeline includes leading programs in chronic hepatitis delta virus (HDV) and strategically expanding into oncology. They have demonstrated their ability to discover and develop antibody-based medicines for COVID-19 and Ebola.

## Market Standing
- **Valuation/Market Cap**: Market cap fluctuates with stock price. As of recent reporting, it is in the range of several billion USD. For the most current figure, refer to financial data providers.
- **Key Metric**: As a public company, key metrics include R&D spending, cash position, and pipeline progress. The company had significant revenue from its COVID-19 antibody partnership (sotrovimab) but is now focused on advancing its pipeline.
- **Notable Investors/Partners**: Founding investors include ARCH Venture Partners and the Bill & Melinda Gates Foundation. Key partners include Alnylam Pharmaceuticals and Sanofi (via the Amunix/PRO-XTEN platform).
- **Growth Signals**: The company is actively expanding its oncology pipeline, appointing an SVP of Oncology and a Vice President of Clinical Research-Oncology. It continues to hire across R&D, regulatory, and business development, signaling a phase of growth and pipeline advancement.

## Competitive Advantages
- **Deep Immunology Expertise**: The company has a world-class team with deep knowledge of immunology and antibody engineering.
- **Dual-Platform Strategy**: Combining a powerful antibody discovery platform with the PRO-XTEN® masking technology gives it a unique ability to create both potent and safer therapies.
- **Proven Track Record**: Successfully developed and brought to market a COVID-19 antibody (sotrovimab) and an Ebola treatment (mAb114) on an accelerated timeline, demonstrating execution capability.
- **Focus on Unmet Needs**: Concentrates on diseases with limited treatment options, such as chronic hepatitis delta and hard-to-treat cancers.

## Strategic Focus
- **Infectious Disease Foundation**: Continuing to advance its core programs in infectious diseases, with a leading program in chronic hepatitis delta.
- **Strategic Oncology Expansion**: Building a robust oncology pipeline using its antibody and PRO-XTEN® platforms, with a focus on indications with high unmet need.
- **Pipeline Acceleration**: Leveraging its platforms to rapidly identify, optimize, and advance candidates from concept to clinic.
- **Building for the Long Term**: The company is strategically building its capabilities and team to become a multi-product, multi-indication biotech.

## Why Work Here
- **Mission-Driven**: Employees are directly contributing to developing transformative medicines for patients with serious diseases.
- **World-Class Team**: Opportunity to work alongside industry-leading scientists, clinicians, and business leaders in the U.S. and Europe.
- **Commitment to Fair Pay**: The company has an "unwavering commitment to fair pay" with a rigorous, proactive approach to compensation based on skills and experience. U.S. salary ranges are shared internally for transparency.
- **Generous Benefits**: Includes health benefits and wellness program, unaccrued time off with structured holidays, on-site paid parking, lunch, and transit spending account (in the U.S.).
- **Workplace Culture**: The company emphasizes "Virtues" over values and a culture of urgency and impact.
- **Locations**: Primarily San Francisco, CA, with some remote options for specific roles (e.g., Regulatory Writer). European offices are also part of the company.

## Sources
1. [vir.bio](https://www.vir.bio/)
2. [vir.bio/careers](https://www.vir.bio/careers/)
3. [job-boards.greenhouse.io/virbiotechnologyinc](http://job-boards.greenhouse.io/virbiotechnologyinc)
4. [vir.bio/about/strategy](https://www.vir.bio/about/strategy/)

## Other roles at Vir Biotechnology

- [Senior Director, Head of Clinical Pharmacology](https://feeny.ai/job/senior-director-head-of-clinical-pharmacology-vir-biotechnology-united-states-3rhq3yhvnnf1) — United States
- [SVP, Regulatory Affairs](https://feeny.ai/job/svp-regulatory-affairs-vir-biotechnology-san-francisco-q3eswvctgp3v) — San Francisco, CA
- [Director, Clinical Contracts](https://feeny.ai/job/director-clinical-contracts-vir-biotechnology-san-francisco-ann0130xxcqz) — San Francisco, CA
- [Senior Director, Total Rewards and HRIS](https://feeny.ai/job/senior-director-total-rewards-and-hris-vir-biotechnology-san-francisco-cbww9w8dee7n) — San Francisco, CA
- [Senior Director, Clinical Research-Program Executive-Oncology](https://feeny.ai/job/senior-director-clinical-research-program-executive-oncology-vir-biotechnology-r41tr7w00x99) — San Francisco, CA
- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-vir-biotechnology-san-francisco-ajxvfttp1cq5) — San Francisco, CA
- [Associate Director, CMC Project Management](https://feeny.ai/job/associate-director-cmc-project-management-vir-biotechnology-san-francisco-rgwkehm4691f) — San Francisco, CA
- [Associate Director, Quality Systems (Temporary)](https://feeny.ai/job/associate-director-quality-systems-temporary-vir-biotechnology-san-francisco-x0xjcec1q94g) — San Francisco, CA
- [Senior Specialist, QA Operations (Temporary)](https://feeny.ai/job/senior-specialist-qa-operations-temporary-vir-biotechnology-san-francisco-mjvvaa0hjtne) — San Francisco, CA
- [Senior Scientist I, Drug Product & Device Development (Temporary)](https://feeny.ai/job/senior-scientist-i-drug-product-device-development-temporary-vir-biotechnology-yxcegjgez7qk) — San Francisco, CA